青少年肝移植后的捐赠者-接受者年龄不匹配和长期移植结果
Toshihiro Nakayama1,2, Amanda R Jensen1,2, Antony Attia1,2
1Stanford Transplant Outcomes Research Center (STORC), Division of Abdominal Transplantation, Stanford University Medical Center, Stanford, California.
JAMA network open
|January 7, 2026
概括
青少年肝移植 (LTs) 中的捐赠者-接受者年龄不匹配与较差的移植存活率有关. 扩大供体共享可以改善对年龄相匹配器官的获取,并改善年轻患者的长期结果.
科学领域:
- 移植免疫学 移植免疫学
- 儿科外科手术 儿科外科手术
- 器官捐赠和分配器官的情况.
背景情况:
- 捐赠者与接受者的年龄不匹配是成年人肝移植 (LTs) 的已知风险因素.
- 年龄不匹配对青少年LTs移植耐久性的影响尚不清楚.
- 由于分配政策,青少年可能会接受较老的捐赠肝脏,限制了对年龄相匹配的移植的访问.
研究的目的:
- 确定10年或更长的捐赠者-接受者年龄差异是否会影响青少年LTs的移植存活率.
- 估计青少年捐献肝脏在更广泛的地理区域共享的好处.
主要方法:
- 使用美国器官采购和移植网络数据进行了回顾性,基于注册表的病例控制研究.
- 包括接受仅肝脏移植 (2002-2024) 的青少年 (12-17岁).
- 倾向性得分匹配 (1:1) 用于控制混变量;10年移植存活是主要结果.
主要成果:
- 在2020年的青少年中,612人 (30.3%) 接受了年龄不匹配的移植 (≥10年差异).
- 在匹配后,年龄不匹配的10年移植存活率为61.5%,年龄匹配的74.2% (P < .001).
- 将分配半径扩大到1000海里公里可以使90%的候选人能够在15天内收到年龄匹配的报价.
结论:
- 捐赠者-接受者年龄不匹配 (≥10岁) 与青少年肝移植接受者的移植存活率显著下降有关.
- 对于青少年捐赠者而言,更广泛的分配政策可以改善获得年龄相匹配的移植的机会.
- 扩大供体共享可能会提高长期移植和患者在这个群体的结果.
更多相关视频
08:39Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
8.3K
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
2.2K
相关概念视频
Kidney Transplant I: Introduction
321
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
321
Tissue Transplantation
885
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
885
Bone Marrow Sampling and Transplants
858
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
858
Kidney Transplant II: Surgical Procedure
297
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
297
